Prevalence of intrauterine adhesions after NovaSure ablation with application of Hyaluronic acid
- Conditions
- Intraurineadhesions after endometrial ablation
- Registration Number
- NL-OMON23959
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
•Women suffering symptoms from HMB, scheduled for a NovaSure endometrial ablation
•Women in pre-menopausal age
Exclusion Criteria
•Women younger than 34
•Women with a desire to preserve fertility
•Women with intracavitary pathology or big intramural myoma seen by transvaginal ultrasound.
•Women with a history of a previous endometrial ablation or curettage
•Women with cervix pathology
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will investigate the prevalence and describe the severity of IUAs (using a valid scoring system, the American Fertility Society (AFS) classification system) following NovaSure treatment for HMB with NCH gel compared to a NovaSure treatment without the NCH gel. In order to prepare for a future hypothesis testing randomized trial.
- Secondary Outcome Measures
Name Time Method We will also investigate the complications (like uterus perforation and infection) that can occur during administration of the NCH gel in the uterus. Also, we will investigate dysmenorrhoea/ abdominal pain, PBAC score and menstrual bleeding pattern and patient’s satisfaction between the group of patients following NovaSure treatment with NCH and without the NCH gel.